Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Kinder Morgan
KMI
$69B
| $1.25M | 0.03% |
+74,749
| New | +$1.4M |
|
752
Tandem Diabetes Care
TNDM
$1.55B
| $1.25M | 0.03% |
+21,169
| New | +$1.74M |
|
|
INN
753
Summit Hotel Properties
INN
$661M
| $1.25M | 0.03% |
172,243
+140,556
| +444% | +$1.24M |
|
754
PBF Energy
PBF
$8.24B
| $1.25M | 0.03% |
43,086
+15,637
| +57% | +$489K |
|
|
TETE
755
DELISTED
Technology & Telecommunication Acquisition Corporation Class A Ordinary Shares
TETE
| $1.25M | 0.03% |
125,000
| – | – |
|
756
Viasat
VSAT
$9.95B
| $1.25M | 0.03% |
+40,667
| New | +$1.57M |
|
|
CNR
757
Core Natural Resources Inc
CNR
$4.78B
| $1.25M | 0.03% |
+25,224
| New | +$1.23M |
|
|
EONR
758
EON Resources
EONR
$24.1M
| $1.25M | 0.03% |
+125,000
| New | +$1.25M |
|
|
CYBR
759
DELISTED
CyberArk
CYBR
| $1.24M | 0.03% |
9,680
+3,514
| +57% | +$508K |
|
760
Bunge Global
BG
$21.2B
| $1.24M | 0.03% |
13,621
-26,165
| -66% | -$2.9M |
|
761
CALL
Freeport-McMoran
FCX
$112B
| $1.24M | 0.03% |
42,100
+30,200
| +254% | +$1.21M |
|
|
SBNY
762
DELISTED
Signature Bank
SBNY
| $1.23M | 0.03% |
6,870
+538
| +8% | +$121K |
|
|
PCH
763
DELISTED
PotlatchDeltic
PCH
| $1.23M | 0.03% |
+27,788
| New | +$1.43M |
|
764
Compass Minerals
CMP
$1.03B
| $1.23M | 0.03% |
+34,607
| New | +$1.71M |
|
765
Insmed
INSM
$27.1B
| $1.22M | 0.03% |
62,034
+16,664
| +37% | +$349K |
|
|
SLCA
766
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.22M | 0.03% |
+107,001
| New | +$1.8M |
|
767
CALL
Chubb
CB
$133B
| $1.22M | 0.03% |
6,200
+3,100
| +100% | +$639K |
|
768
Brinker International
EAT
$10.9B
| $1.22M | 0.03% |
+55,298
| New | +$1.75M |
|
769
Boston Properties
BXP
$11.2B
| $1.22M | 0.03% |
+13,675
| New | +$1.51M |
|
770
Simmons First National
SFNC
$3.32B
| $1.22M | 0.03% |
57,180
+48,499
| +559% | +$1.18M |
|
771
Liberty Energy
LBRT
$3.01B
| $1.22M | 0.03% |
95,202
+82,172
| +631% | +$1.29M |
|
772
Traeger
COOK
$157M
| $1.21M | 0.03% |
5,707
+4,461
| +358% | +$1.24M |
|
|
VRAY
773
DELISTED
ViewRay, Inc.
VRAY
| $1.21M | 0.03% |
457,121
+121,258
| +36% | +$365K |
|
774
Aaon
AAON
$6.28B
| $1.21M | 0.03% |
33,155
-67,381
| -67% | -$2.36M |
|
775
Hertz
HTZ
$777M
| $1.21M | 0.03% |
76,391
+10,585
| +16% | +$209K |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.